Forbes, Josephine M.

Mechanisms of Diabetic Complications

Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 2,890

Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes

Forbes, J. M., Coughlan, M. T., & Cooper, M. E. (2008) · Diabetes

Chronic Kidney Disease and DiabetesAdvanced Glycation End Products research

Cited by 1,203

High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus

Drew, B. G., Duffy, S. J., Formosa, M. F., Natoli, A. K., Henstridge, D. C., Penfold, S. A., Thomas, W. G., Mukhamedova, N., de Courten, B., Forbes, J. M., et al. (2009) · Circulation

Diabetes, Cardiovascular Risks, and LipoproteinsMetabolism, Diabetes, and Cancer

Cited by 443

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes

Advanced Glycation End Products researchAtherosclerosis and Cardiovascular Diseases

Cited by 407

Role of Advanced Glycation End Products in Diabetic Nephropathy

Forbes, J. M., Cooper, M. E., Oldfield, M. D., & Thomas, M. C. (2003) · Journal of the American Society of Nephrology

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 351

Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products

Fernando, D. H., Forbes, J. M., Angus, P. W., & Herath, C. B. (2019) · International Journal of Molecular Sciences

Liver Disease Diagnosis and TreatmentAdvanced Glycation End Products research

Cited by 184

Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation

Sourris, K. C., Ding, Y., Maxwell, S. S., Al-sharea, A., Kantharidis, P., Mohan, M., Rosado, C. J., Penfold, S. A., Haase, C., Xu, Y., et al. (2024) · Kidney International

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 143

Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy?

Coughlan, M. T., Thallas-Bonke, V., Pete, J., Long, D. M., Gasser, A., Tong, D. C. K., Arnstein, M., Thorpe, S. R., Cooper, M. E., & Forbes, J. M. (2007) · Endocrinology

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 124

Vascular complications in diabetes: Old messages, new thoughts

Forbes, J. M., & Fotheringham, A. K. (2017) · Diabetologia

Diabetes Management and ResearchAdvanced Glycation End Products research

Cited by 106

Dietary glycotoxins exacerbate progression of experimental fatty liver disease

Leung, C., Herath, C. B., Jia, Z., Goodwin, M., Mak, K. Y., Watt, M. J., Forbes, J. M., & Angus, P. W. (2014) · Journal of Hepatology

Liver Disease Diagnosis and TreatmentAdvanced Glycation End Products research

Cited by 88

Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease

Leung, C., Herath, C. B., Jia, Z., Andrikopoulos, S., Brown, B. E., Davies, M. J., Rivera, L. R., Furness, J. B., Forbes, J. M., & Angus, P. W. (2016) · World Journal of Gastroenterology

Liver Disease Diagnosis and TreatmentAdvanced Glycation End Products research

Cited by 80

Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial

Baye, E., de Courten, M. P., Walker, K., Ranasinha, S., Earnest, A., Forbes, J. M., & de Courten, B. (2017) · Scientific Reports

Advanced Glycation End Products researchNutritional Studies and Diet

Cited by 50